PTGS2 and inflammation: Brain inflammation induced through systemic LPS exposure is clinically relevant, and our current findings indicated that systemic LPS exposure (P5) through an i.p. injection induced central inflammation; these inflammatory responses included induction of COX-2 expression in TH neurons and astrocytes.